Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
8.78M
-
Shares change
-
-1.64M
-
Total reported value, excl. options
-
$9.66M
-
Value change
-
-$1.74M
-
Number of buys
-
5
-
Number of sells
-
-10
-
Price
-
$1.10
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2020
24 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q1 2020.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.78M shares
of 386M outstanding shares and own 2.28% of the company stock.
Largest 10 shareholders include STONEHILL CAPITAL MANAGEMENT LLC (3M shares), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1.56M shares), Paradice Investment Management LLC (1.54M shares), HEARTLAND ADVISORS INC (885K shares), RENAISSANCE TECHNOLOGIES LLC (874K shares), Invenomic Capital Management LP (401K shares), Fondren Management LP (230K shares), MILLENNIUM MANAGEMENT LLC (109K shares), MORGAN STANLEY (57.6K shares), and TWO SIGMA ADVISERS, LP (30.5K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.